BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9699884)

  • 21. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
    Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
    Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
    Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
    Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
    J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.
    Kaeding J; Bouchaert E; Bélanger J; Caron P; Chouinard S; Verreault M; Larouche O; Pelletier G; Staels B; Bélanger A; Barbier O
    Biochem J; 2008 Mar; 410(2):245-53. PubMed ID: 17988216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line.
    Bélanger G; Beaulieu M; Marcotte B; Lévesque E; Guillemette C; Hum DW; Bélanger A
    Mol Cell Endocrinol; 1995 Sep; 113(2):165-73. PubMed ID: 8674824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry.
    Barbier O; Lapointe H; El Alfy M; Hum DW; Bélanger A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4819-26. PubMed ID: 11134149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.
    Margaillan G; Lévesque É; Guillemette C
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):85-93. PubMed ID: 26385605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues.
    Albert C; Barbier O; Vallée M; Beaudry G; Bélanger A; Hum DW
    Endocrinology; 2000 Jul; 141(7):2472-80. PubMed ID: 10875248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The androgen-conjugating uridine diphosphoglucuronosyltransferase-2B enzymes are differentially expressed temporally and spatially in the monkey follicle throughout the menstrual cycle.
    Barbier O; Girard C; Berger L; El Alfy M; Bélanger A; Hum DW
    Endocrinology; 2001 Jun; 142(6):2499-507. PubMed ID: 11356699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
    Guillemette C; Hum DW; Bélanger A
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):355-62. PubMed ID: 8541232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
    Harrington WR; Sengupta S; Katzenellenbogen BS
    Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation.
    Chouinard S; Pelletier G; Bélanger A; Barbier O
    Endocrinology; 2006 Nov; 147(11):5431-42. PubMed ID: 16887906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens.
    Beaulieu M; Lévesque E; Barbier O; Turgeon D; Bélanger G; Hum DW; Bélanger A
    J Mol Biol; 1998 Feb; 275(5):785-94. PubMed ID: 9480769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.
    Hu DG; Mackenzie PI
    Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential.
    Zimmer BM; Howell ME; Wei Q; Ma L; Romsdahl T; Loughman EG; Markham JE; Seravalli J; Barycki JJ; Simpson MA
    Horm Cancer; 2016 Aug; 7(4):260-71. PubMed ID: 27307252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C
    du Toit T; Swart AC
    Mol Cell Endocrinol; 2018 Feb; 461():265-276. PubMed ID: 28939401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
    Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
    Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase.
    Lévesque E; Turgeon D; Carrier JS; Montminy V; Beaulieu M; Bélanger A
    Biochemistry; 2001 Apr; 40(13):3869-81. PubMed ID: 11300766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UGT2B23, a novel uridine diphosphate-glucuronosyltransferase enzyme expressed in steroid target tissues that conjugates androgen and estrogen metabolites.
    Barbier O; Lévesque E; Bélanger A; Hum DW
    Endocrinology; 1999 Dec; 140(12):5538-48. PubMed ID: 10579317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
    Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
    J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.